LifePoint Health (LPNT) Scheduled to Post Quarterly Earnings on Friday

LifePoint Health (NASDAQ:LPNT) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, February 23rd. Analysts expect the company to announce earnings of $0.83 per share for the quarter.

LifePoint Health (NASDAQ LPNT) opened at $48.85 on Friday. The company has a market cap of $1,930.00, a price-to-earnings ratio of 11.58, a PEG ratio of 1.08 and a beta of 0.52. LifePoint Health has a twelve month low of $42.50 and a twelve month high of $70.95. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24.

LifePoint Health declared that its Board of Directors has approved a share buyback program on Friday, October 27th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

LPNT has been the topic of a number of research analyst reports. Raymond James Financial reissued a “market perform” rating on shares of LifePoint Health in a report on Monday, October 30th. Robert W. Baird set a $55.00 price objective on shares of LifePoint Health and gave the company a “buy” rating in a research note on Monday, October 30th. SunTrust Banks set a $54.00 price objective on shares of LifePoint Health and gave the company a “hold” rating in a research note on Tuesday, October 31st. William Blair reaffirmed an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Finally, Citigroup cut their price objective on shares of LifePoint Health from $70.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 30th. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $58.67.

In other LifePoint Health news, insider David M. Dill sold 45,000 shares of the stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Marguerite Kondracke sold 3,907 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total transaction of $174,760.11. The disclosure for this sale can be found here. Insiders have sold a total of 52,323 shares of company stock valued at $2,507,781 in the last three months. 8.76% of the stock is currently owned by corporate insiders.

WARNING: “LifePoint Health (LPNT) Scheduled to Post Quarterly Earnings on Friday” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/16/lifepoint-health-lpnt-scheduled-to-post-quarterly-earnings-on-friday.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply